Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nora Goly"'
Autor:
Manuel Neuberger, Christel Weiß, Nora Goly, Janina Skladny, Katja Nitschke, Frederik Wessels, Karl F. Kowalewski, Frank Waldbillig, Friedrich Hartung, Malin Nientiedt, Luisa Egen, Jonas Herrmann, Jonas Jarczyk, Margarete Teresa Walach, Maximilian C. Kriegmair, Niklas Westhoff, Thomas S. Worst, Philipp Nuhn
Publikováno v:
Discover Oncology, Vol 13, Iss 1, Pp 1-12 (2022)
Abstract Objectives To assess the predictive and prognostic value of changes in longitudinal neutrophile-to-lymphocyte (NLR) ratios in men receiving taxane-based chemotherapy for metastatic prostate cancer (PC). Methods Retrospective, unicentric coho
Externí odkaz:
https://doaj.org/article/ac13e6972f414f87831c525004e94f2a
Autor:
Manuel, Neuberger, Nora, Goly, Janina, Skladny, Veronica, Milczynski, Christel, Weiß, Frederik, Wessels, Katja, Nitschke, Britta, Grüne, Caelán M, Haney, Friedrich, Hartung, Jonas, Herrmann, Jonas, Jarczyk, Karl F, Kowalewski, Frank, Waldbillig, Maximilian C, Kriegmair, Niklas, Westhoff, Thomas S, Worst, Philipp, Nuhn
Publikováno v:
Journal of Cancer Research and Clinical Oncology.
Purpose Advances in therapy of metastatic castration-refractory prostate cancer (mCRPC) resulted in more therapeutic options and led to a higher need of predictive/prognostic biomarkers. Systemic inflammatory biomarkers could provide the basis for pe
Autor:
MANUEL NEUBERGER, JANINA SKLADNY, NORA GOLY, FREDERIK WESSELS, CHRISTEL WEIß, LUISA EGEN, PHILIPP ERBEN, MATTHIAS GROß-WEEGE, BRITTA GRÜNE, FRIEDRICH HARTUNG, JONAS HERRMANN, PATRICK HONECK, JONAS JARCZYK, KARL-FRIEDRICH KOWALEWSKI, JULIA MÜHLBAUER, KATJA NITSCHKE, MALIN NIENTIEDT, MARGARETE THERESA WALACH, FRANK WALDBILLIG, NIKLAS WESTHOFF, JOST VON HARDENBERG, MAXIMILIAN KRIEGMAIR, THOMAS S. WORST, PHILIPP NUHN
Publikováno v:
Anticancer research. 42(4)
To assess the baseline inflammatory markers modified Glasgow Prognostic Score (mGPS), systemic immune-inflammation index (SII), and neutrophile-to-lymphocyte ratio (NLR) as pragmatic tools for predicting response to chemohormonal therapy (docetaxel p